300813 泰林生物
按盤價 
24.720 +0.160 (+0.651%)
24.720 +0.160 (+0.651%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.829 | 1.777 | 3.035 | 13.921 | 13.494 |
| 總資產報酬率 ROA (%) | 1.555 | 1.350 | 2.075 | 10.096 | 10.625 |
| 投入資產回報率 ROIC (%) | 1.652 | 1.443 | 2.220 | 10.868 | 11.642 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.593 | 43.517 | 47.565 | 52.586 | 61.878 |
| 營業利潤率 (%) | 7.328 | 3.553 | 8.070 | 21.294 | 24.640 |
| 息稅前利潤/營業總收入 (%) | 4.306 | 5.101 | 4.146 | 18.990 | 22.265 |
| 淨利潤/營業總收入 (%) | 6.812 | 3.511 | 6.835 | 21.313 | 22.429 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 78.762 | 6.558 | 26.621 | 77.218 | 84.682 |
| 價值變動淨收益/利潤總額(%) | 4.535 | 14.529 | -0.053 | 0.451 | 3.576 |
| 營業外收支淨額/利潤總額(%) | -3.624 | 2.881 | 0.898 | 0.419 | -0.215 | 償債能力分析 |
| 流動比率 (X) | 3.875 | 4.660 | 3.948 | 5.904 | 3.352 |
| 速動比率 (X) | 2.783 | 3.599 | 2.955 | 5.044 | 2.554 |
| 資產負債率 (%) | 15.408 | 14.499 | 33.207 | 29.827 | 24.165 |
| 帶息債務/全部投入資本 (%) | 9.730 | 8.880 | 27.876 | 25.266 | 16.206 |
| 股東權益/帶息債務 (%) | 923.977 | 1,021.866 | 257.202 | 295.608 | 511.871 |
| 股東權益/負債合計 (%) | 549.020 | 589.208 | 200.688 | 235.263 | 313.823 |
| 利息保障倍數 (X) | -1.557 | 3.536 | -1.037 | -7.934 | -9.584 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 58.626 | 41.069 | 52.468 | 39.026 | 35.814 |
| 存貨周轉天數 (天) | 397.751 | 278.218 | 345.695 | 237.246 | 309.462 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
